Jpmorgan Chase & CO Emergent Bio Solutions Inc. Transaction History

Jpmorgan Chase & CO

$1.22 Trillion
Q3 2024

A detailed history of Jpmorgan Chase & CO transactions in Emergent Bio Solutions Inc. stock. As of the latest transaction made, Jpmorgan Chase & CO holds 643 shares of EBS stock, worth $5,709. This represents 0.0% of its overall portfolio holdings.

Number of Shares

643

Previous 649,502 99.9%

Holding current value

$5,709

Previous $4.43 Million 99.89%

% of portfolio

0.0%

Previous 0.0%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 08, 2024	SELL	$5.72 - $14.77 $3.71 Million - $9.58 Million	-648,859 Reduced 99.9%	643 $5,000
Q2 2024 Aug 12, 2024	BUY	$1.86 - $6.98 $699,289 - $2.62 Million	375,962 Added 137.44%	649,502 $4.43 Million
Q1 2024 May 10, 2024	BUY	$1.5 - $3.41 $333,874 - $759,008	222,583 Added 436.81%	273,540 $692,000
Q4 2023 Feb 12, 2024	SELL	$1.82 - $3.16 $440 - $764	-242 Reduced 0.47%	50,957 $122,000
Q3 2023 Nov 14, 2023	BUY	$3.17 - $7.91 $24,913 - $62,164	7,859 Added 18.13%	51,199 $174,000
Q2 2023 Aug 11, 2023	SELL	$7.35 - $13.21 $196,399 - $352,984	-26,721 Reduced 38.14%	43,340 $318,000
Q1 2023 May 18, 2023	BUY	$7.79 - $16.29 $469,900 - $982,629	60,321 Added 619.31%	70,061 $725,000
Q1 2023 May 11, 2023	SELL	$7.79 - $16.29 $1.83 Million - $3.82 Million	-234,503 Reduced 96.01%	9,740 $100,000
Q4 2022 Feb 13, 2023	BUY	$11.0 - $21.45 $1.99 Million - $3.89 Million	181,213 Added 287.5%	244,243 $2.88 Million
Q3 2022 Nov 14, 2022	SELL	$20.09 - $35.8 $2.09 Million - $3.73 Million	-104,184 Reduced 62.31%	63,030 $1.32 Million
Q2 2022 Aug 11, 2022	BUY	$27.42 - $43.63 $230,903 - $367,408	8,421 Added 5.3%	167,214 $5.19 Million
Q1 2022 May 11, 2022	BUY	$36.48 - $52.22 $4.05 Million - $5.79 Million	110,909 Added 231.62%	158,793 $6.52 Million
Q4 2021 Feb 10, 2022	SELL	$33.11 - $55.01 $1.56 Million - $2.59 Million	-47,003 Reduced 49.54%	47,884 $2.08 Million
Q3 2021 Nov 12, 2021	BUY	$50.07 - $66.05 $4.75 Million - $6.27 Million	94,887 New	94,887 $4.75 Million

Others Institutions Holding EBS

# of Institutions

159

Shares Held

33.7M

Call Options Held

453K

Put Options Held

931K

View Full List

About Emergent BioSolutions Inc.

Ticker EBS
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 49,861,500
Market Cap $443M
Description
Emergent BioSolutions Inc., a life sciences company, focuses on the provision of preparedness and response solutions that address accidental, deliberate, and naturally occurring public health threats (PHTs) in the United States. The company's products address PHTs, which include chemical, biological, radiological, nuclear, and explosives; emergi...

More about EBS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Jpmorgan Chase & CO, based on Form 13F filings with the SEC.

News

Stay updated on Jpmorgan Chase & CO with notifications on news.

Account

Jpmorgan Chase & CO Emergent Bio Solutions Inc. Transaction History